Liver drug maralixibat passes Long-Term safety check in rare disease patients
NCT ID NCT04168385
First seen Jan 04, 2026 · Last updated May 22, 2026 · Updated 20 times
Summary
This study looked at the long-term safety of a drug called maralixibat in 52 people with cholestatic liver diseases like Alagille syndrome and PFIC. All participants had taken maralixibat before in earlier studies. The main goal was to track side effects over time, and researchers also checked if itching and bile acid levels improved.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOLESTATIC LIVER DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Baylor College of Medicine/Texas Children's Hospital
Houston, Texas, 77030, United States
-
Birmingham Children's Hospital
Birmingham, United Kingdom
-
Children Hospital of Pittsburgh
Pittsburgh, Pennsylvania, 15224, United States
-
Children'S Hospital Los Angeles
Los Angeles, California, 90027, United States
-
Children's Hospital Westmead
Westmead, New South Wales, 2145, Australia
-
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
-
Cliniques Universitaires Saint-Luc
Brussels, Belgium
-
Hopital Kremlin Bicetre
Paris, 94275, France
-
Hopital Necker-Enfants Malades
Paris, 75015, France
-
Hospital Universitario La Paz- Hospital Materno Infantil
Madrid, 261, Spain
-
Hospital for Sick Children
Toronto, Canada
-
Leeds Teaching Hospital NHS Trust
Leeds, LS1 3EX, United Kingdom
-
Paediatric Liver Center, Kings College Hospital
London, SE5 9RS, United Kingdom
-
Riley Hospital For Children
Indianapolis, Indiana, 46202, United States
-
Seattle Children's Hospital
Seattle, Washington, 98105, United States
-
The Children's Memorial Health Institute
Warsaw, 04-730, Poland
-
The Royal Children'S Hospital Melbourne
Parkville, Victoria, 3052, Australia
Conditions
Explore the condition pages connected to this study.